Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11382932 Genetically engineered hematopoietic stem cells and uses thereof

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
April 5, 2021
Date of Patent
July 12, 2022
Patent Application Number
17222855
Patent Citations
‌
US Patent 10786535 Compositions and methods for inhibition of lineage specific antigens
‌
US Patent 10137155 Compositions and methods for inhibition of lineage specific antigens
‌
US Patent 10201606 Combination immunotherapy of antigen-recognizing receptors and hematopoietic cells for the treatment of diseases
0
‌
US Patent 10548922 Methods and compositions for gene editing in hematopoietic stem cells
0
‌
US Patent 10668103 Compositions and methods for inhibition of lineage specific antigens
‌
US Patent 10660919 Compositions and methods for inhibition of lineage specific antigens
0
‌
US Patent 11033619 Combination of immune effector cells specific for a target antigen and hematopoietic cells that express the target antigen in an altered form
0
‌
US Patent 10925902 Genetically engineered hematopoietic stem cells and uses thereof
0
‌
US Patent 10912799 Compositions and methods for inhibition of lineage specific antigens
Patent Citations Received
‌
US Patent 11975029 Compositions and methods for inhibition of lineage specific proteins
0
‌
US Patent 11903973 Genetically engineered hematopoietic stem cells and uses thereof
0
Patent Inventor Names
Joseph Bolen
0
John Lydeard
0
Aleksandar Filip Radovic-Moreno
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11382932
Patent Primary Examiner
‌
Ilia I Ouspenski

Find more entities like US Patent 11382932 Genetically engineered hematopoietic stem cells and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo